Synlogic Inc (SYBX)

NASDAQ
3.290
+0.100(+3.13%)
After Hours
3.290
0.000(0.00%)
- Real-time Data
  • Volume:
    272,814
  • Bid/Ask:
    3.230/3.330
  • Day's Range:
    3.120 - 3.340
  • Type:Equity
  • Market:United States
  • ISIN:US87166L1008
  • CUSIP:00087166L100

SYBX Overview

Prev. Close
3.19
Day's Range
3.12-3.34
Revenue
250K
Open
3.21
52 wk Range
1.78-5.11
EPS
-1.39
Volume
272,814
Market Cap
172.31M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
223,919
P/E Ratio
-
Beta
1.79
1-Year Change
53.02%
Shares Outstanding
52,373,311
Next Earnings Date
Nov 16, 2021
What is your sentiment on Synlogic Inc?
or
Market is currently closed. Voting is open during market hours.

Synlogic Inc News

Synlogic Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuySell
SummaryStrong BuyStrong BuyStrong BuyStrong BuySell

Synlogic Inc Company Profile

Synlogic Inc Company Profile

Employees
72

Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.

Read More
  • 1/12/21 50 day EMA crossed above 100 day EMA buy signal. time to buy and hold
    0
    • Synology have 3 drugs on clinical trial.it is going sky rocket to $8
      0
      • split
        1
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.